{"id":26250,"date":"2025-11-05T14:53:08","date_gmt":"2025-11-05T07:53:08","guid":{"rendered":"https:\/\/nhathuocngocanh.com\/bp\/?p=26250"},"modified":"2025-11-05T14:53:08","modified_gmt":"2025-11-05T07:53:08","slug":"pentamidine-isetionate","status":"publish","type":"post","link":"https:\/\/nhathuocngocanh.com\/bp\/pentamidine-isetionate\/","title":{"rendered":"Pentamidine Isetionate"},"content":{"rendered":"

(Pentamidine Diisetionate, Ph. Eur. monograph 1137)<\/em><\/p>\n

C23<\/sub>H36<\/sub>N4<\/sub>O10<\/sub>S2<\/sub> 592.7 140-64-7<\/p>\n

Action and use<\/strong><\/p>\n

Antiprotozoal.<\/p>\n

Preparation<\/strong><\/p>\n

Pentamidine Injection<\/p>\n

DEFINITION<\/h2>\n

4,4\u2032-[Pentane-1,5-diylbis(oxy)]dibenzimidamide bis(2 hydroxyethanesulfonate).<\/p>\n

Content<\/h3>\n

98.5 per cent to 101.5 per cent (dried substance).<\/p>\n

PRODUCTION<\/h2>\n

It is considered that alkyl 2-hydroxyethanesulfonate esters are potential impurities in pentamidine diisetionate. The manufacturing process should be developed taking into consideration the principles of quality risk management, together with considerations of the quality of starting materials, process capability and validation including, where necessary, demonstration that alkyl 2-hydroxyethanesulfonate esters are not detectable in the final product.<\/p>\n

CHARACTERS<\/h2>\n

Appearance<\/h3>\n

White or almost white powder or colourless crystals, hygroscopic.<\/p>\n

Solubility<\/h3>\n

Freely soluble in water, sparingly soluble in ethanol (96 per cent), practically insoluble in methylene chloride.<\/p>\n

IDENTIFICATION<\/h2>\n

A. Infrared absorption spectrophotometry (2.2.24).<\/p>\n

Preparation: Discs.<\/p>\n

Comparison: pentamidine diisetionate CRS.<\/p>\n

B. Dissolve about 40 mg in 5 mL of water R and add dropwise with shaking 1 mL of a 10 g\/L solution of sodium chloride R. Allow to stand for 5 min. The mixture remains clear.<\/p>\n

C. Treat 0.15 g by the oxygen-flask method (2.5.10). Use 10 mL of dilute hydrogen peroxide solution R to absorb the combustion products. The solution gives reaction (a) of sulfates (2.3.1).<\/p>\n

TESTS<\/h2>\n

Appearance of solution<\/h3>\n

The solution is not more opalescent than reference suspension II (2.2.1) and not more intensely coloured than intensity 6 of the range of reference solutions of the most appropriate colour (2.2.2, Method II).<\/p>\n

Dissolve 2.0 g in water R and dilute to 20 mL with the same solvent.<\/p>\n

pH (2.2.3)<\/h3>\n

4.5 to 6.5.<\/p>\n

Dissolve 0.5 g in carbon dioxide-free water R and dilute to 10 mL with the same solvent.<\/p>\n

Related substances<\/h3>\n

Liquid chromatography (2.2.29).<\/p>\n

Test solution: Dissolve 0.100 g of the substance to be examined in the mobile phase and dilute to 100.0 mL with the mobile phase.<\/p>\n

Reference solution (a): Dilute 2.0 mL of the test solution to 100.0 mL with the mobile phase. Dilute 1.0 mL of this solution to 10.0 mL with the mobile phase.<\/p>\n

Reference solution (b): To 0.1 g in a conical flask, add 40 mL of water R and glass beads. Adjust to pH 10.5 with dilute sodium hydroxide solution R and boil under reflux for 20 min. Cool and dilute to 50 mL with water R. Dilute 1 mL of the solution to 50 mL with the mobile phase.<\/p>\n

Column:<\/p>\n

\u2014 size: l = 0.25 m, \u00d8 = 4.6 mm;<\/p>\n

\u2014 stationary phase: octadecylsilyl silica gel for chromatography R (5 \u03bcm).<\/p>\n

Mobile phase: Mix 65 volumes of methanol R and 35 volumes of a 30 g\/L solution of ammonium acetate R previously adjusted to pH 7.5 with triethylamine R.<\/p>\n

Flow rate: 1 mL\/min.<\/p>\n

Detection: Spectrophotometer at 265 nm.<\/p>\n

Injection: 10 \u03bcL.<\/p>\n

Run time: 3.5 times the retention time of pentamidine.<\/p>\n

System suitability: Reference solution (b):<\/p>\n

\u2014 the chromatogram obtained shows 2 principal peaks;<\/p>\n

\u2014 resolution: minimum 2.0 between the 2 principal peaks.<\/p>\n

Limits:<\/p>\n

\u2014 any impurity: for each impurity, not more than the area of the principal peak in the chromatogram obtained with reference solution (a) (0.2 per cent);<\/p>\n

\u2014 total: not more than twice the area of the principal peak in the chromatogram obtained with reference solution (a) (0.4 per cent);<\/p>\n

\u2014 disregard limit: 0.1 times the area of the principal peak in the chromatogram obtained with reference solution (a) (0.02 per cent).<\/p>\n

Loss on drying (2.2.32)<\/h3>\n

Maximum 4.0 per cent, determined on 1.000 g by drying in an oven at 105 \u00b0C.<\/p>\n

Sulfated ash (2.4.14)<\/h3>\n

Maximum 0.1 per cent, determined on 1.0 g.<\/p>\n

ASSAY<\/h2>\n

Dissolve 0.250 g in 50 mL of dimethylformamide R. Add 0.25 mL of thymol blue solution R. Titrate with 0.1 M tetrabutylammonium hydroxide, under a current of nitrogen R, until the colour of the indicator changes to blue.<\/p>\n

Carry out a blank titration.<\/p>\n

1 mL of 0.1 M tetrabutylammonium hydroxide is equivalent to 29.63 mg of C23<\/sub>H36<\/sub>N4<\/sub>O10<\/sub>S2<\/sub>.<\/p>\n

STORAGE<\/h2>\n

In an airtight container.<\/p>\n

IMPURITIES<\/h2>\n
\"Pentamidine
Pentamidine Isetionate<\/figcaption><\/figure>\n

A. 4-[[5-(4-amidinophenoxy)pentyl]oxy]benzenecarboxamide.<\/p>\n","protected":false},"excerpt":{"rendered":"

(Pentamidine Diisetionate, Ph. Eur. monograph 1137) C23H36N4O10S2 592.7 140-64-7 Action and use Antiprotozoal. Preparation Pentamidine Injection DEFINITION 4,4\u2032-[Pentane-1,5-diylbis(oxy)]dibenzimidamide bis(2 hydroxyethanesulfonate). Content 98.5 per cent to 101.5 per cent (dried substance). PRODUCTION It is considered that alkyl 2-hydroxyethanesulfonate esters are potential impurities in pentamidine diisetionate. The manufacturing process should be developed taking into consideration the principles…<\/p>\n","protected":false},"author":4,"featured_media":26275,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[174],"tags":[],"class_list":["post-26250","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicinal-substances"],"acf":[],"_links":{"self":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/26250","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/comments?post=26250"}],"version-history":[{"count":2,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/26250\/revisions"}],"predecessor-version":[{"id":26277,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/26250\/revisions\/26277"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media\/26275"}],"wp:attachment":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media?parent=26250"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/categories?post=26250"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/tags?post=26250"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}